Halozyme Therapeutics, Inc.
Symbol: HALO (NASDAQ)
75.82
▲ (0.02%) 0.015
Company Description:
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Key Stats
- Today's Open: $75.815
- Today's High: $75.815
- Today's Low: $75.815
- Today's Volume: 99
- Yesterday Close: $75.8
- Yesterday High: $76.34
- Yesterday Low: $74.515
- Yesterday Volume: 1.10M
- Last Min Volume: 10
- Last Min High: $75.815
- Last Min Low: $75.815
- Last Min VWAP: $75.815
Company Profile
- Name: Halozyme Therapeutics, Inc.
- Website: https://www.halozyme.com
- Listed Date: 2004-03-12
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001159036
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $8.87B
- Round Lot: 100
- Outstanding Shares: 116.97M
- Asset Type: CS
RECENT FILINGS FOR HALO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 144 | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-13 | 4 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-10 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-20 | 144 | View |
| 2025-06-13 | 4 | View |
| 2025-05-13 | SCHEDULE 13G | View |
| 2025-05-06 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 8-K | View |
| 2025-05-02 | 4 | View |
Latest News on HALO